Knowde Enhanced TDS
Identification & Functionality
- Chemical Name
- Pharma & Nutraceuticals Functions
- CAS No.
- 9004-65-3
- EC No.
- 618-389-6
- Technologies
- Product Families
- Structure
-
Features & Benefits
- Labeling Claims
- Features
- For Hydrophilic matrix formulation of API and METOLOSE® SR to extend the dissolution. The dosage forms can be obtained by direct compression or granulation process.
- METOLOSE® SR has specifications of particle size which can be suitable for sustained release application.
- Dissolution profile can be easily adjusted by selecting appropriate grade.
- Recommendable amount of METOLOSE® SR is more than 20% in the formulation in order to form the stable gel layer.
Applications & Uses
- Markets
- Applications
- Dosage Form
- Manufacturing Technology
Properties
- Typical Properties
- Particle Size Distribution
- Note
*Values in the table are viscosities of 2 w/w % aqueous solution at 20°C
Value | Units | Test Method / Conditions | |
Hydroxypropoxy Content | 8.5 - 10.5 | % | — |
Methoxy Content | 22.0 - 24.0 | % | — |
Viscosity | 3000 - 5600 | — | — |
Value | Units | Test Method / Conditions | |
Particle Size at D20 | 20 - 40 | µm | — |
Particle Size at D50 | 50 - 80 | µm | — |
Particle Size at D80 | 100 - 160 | µm | — |
Regulatory & Compliance
- Certifications & Compliance
- Grade
Technical Details & Test Data
- Drug Release from Matrix Tablets with Metolose® SR (Viscosity Grade)
-
Packaging & Availability
- Packaging Type
- Package
- Packaging material: Double-layered polyethylene bag in fiber drum
- Net weight: Depending on grades
Storage & Handling
- Storage
Keep dry. Store away from excess heat and sunlight. Store in sealed containers.